Balyasny Asset Management’s Zimmer Biomet ZBH Stock Holding History

Balyasny Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,150	Closed	-$635K	–	2910
2021 Q4	$635K	Buy	+5,150	New	+$674K	﹤0.01%	1563
2020 Q4	–	Sell	-41,200	Closed	-$5.45M	–	1771
2020 Q3	$5.45M	Buy	41,200 +10,300	+33%	+$1.35M	0.04%	580
2020 Q2	$3.58M	Buy	+30,900	New	+$3.56M	0.03%	600
2017 Q4	–	Sell	-190,550	Closed	-$21.7M	–	2367
2017 Q3	$21.7M	Sell	190,550 -236,900	-55%	-$27.3M	0.08%	305
2017 Q2	$53.3M	Buy	+427,450	New	+$50.7M	0.22%	109
2015 Q2	–	Sell	-51,500	Closed	-$5.88M	–	1360
2015 Q1	$5.88M	Buy	+51,500	New	+$5.88M	0.05%	449

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's ZBH Position: Q1 2026 in Review

Balyasny Asset Management increased its Zimmer Biomet (ZBH) stake by 12,817% in Q1 2026, buying an estimated $38.7M and bringing the position to 424,578 shares worth $38.4M. The position accounts for 0.05% of the portfolio, ranked #427.

Balyasny Asset Management first reported a position in ZBH in Q3 2013 and has held it in 40 quarters since. The position peaked at $124M in Q3 2022. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Balyasny Asset Management held 424,578 shares of Zimmer Biomet worth $38.4M as of Q1 2026.
Balyasny Asset Management bought 421,291 Zimmer Biomet shares in Q1 2026, an estimated $38.7M.
Zimmer Biomet made up 0.05% of Balyasny Asset Management's portfolio in Q1 2026, its #427 holding.
Balyasny Asset Management first reported a position in Zimmer Biomet in Q3 2013 and has held it in 40 quarters since.
Balyasny Asset Management's Zimmer Biomet position peaked at $124M in Q3 2022.
914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.